Evidence-led GLP-1 education
← Back to Blog
Treatment questions

Your First Month on GLP-1: Questions to Ask

By Kind MD Editorial Team|August 11, 2026|7 min read
Updated: August 11, 2026
Person tracking questions during an early treatment month
KEY TAKEAWAYS
In This Article
  1. Questions before treatment begins
  2. What variability can look like
  3. How to plan questions and contacts
  4. What to discuss at follow-up
  5. A first-month question list

Questions before treatment begins

Direct answer

Early treatment experiences vary. The prescription, dispensing-pharmacy instructions and provider guidance control the dose, schedule, storage and administration details for your situation.

Before treatment begins, confirm where those instructions live and who to contact when a question comes up. Keep the label, pharmacy materials and care-team contact details together.

Notebook and calendar used to organize treatment questions
A short question list can make an early care conversation easier to navigate.

What variability can look like

People may notice different changes, no obvious change or a change that raises a question. The timing and intensity of an experience do not by themselves tell you whether a prescription is working or whether it should be changed.

Avoid comparing your first month with another person’s story. Formulation, concentration, schedule, health history and other medicines can differ. Use your own written instructions and ask the provider or pharmacist when something is unclear.

How to plan questions and contacts

Save the phone number or secure-message route supplied with your care. When you contact the team, describe what you noticed, when it began, what the written instructions say and what other medicines or health changes may be relevant. Do not improvise a dose or administration change from a blog.

If you have urgent or severe symptoms, seek appropriate urgent medical care. The care team can explain the route for routine questions, but this page is not a symptom protocol.

What to discuss at follow-up

A licensed healthcare provider makes an independent prescribing decision when clinically appropriate. Keep that decision with the provider who knows your health history.

A first-month question list

Bring these questions to your provider or dispensing pharmacy:

  1. Where can I find the current instructions for my prescription?
  2. Who should I contact about administration or storage questions?
  3. What changes should I report, and how should I report them?
  4. When is the next scheduled follow-up?
  5. What information should I track for that conversation?

Educational review boundary This article is for educational purposes. It has not been presented as individualized medical advice or as a clinical/legal approval of the claims discussed.

Frequently asked questions

What should I expect in my first month?

There is no single first-month experience. The prescription, dispensing-pharmacy materials and provider guidance control the details for your situation, and early experiences vary.

Can this page tell me my dose or schedule?

No. Follow the actual prescription and dispensing-pharmacy instructions. A licensed healthcare provider makes an independent prescribing decision when clinically appropriate.

What should I do if I have a question about administration or storage?

Use the contact route supplied by the dispensing pharmacy or prescribing provider. Do not substitute a general blog instruction for the written materials tied to your prescription.

What information should I bring to follow-up?

Bring the written instructions, your questions, relevant health changes and a current list of medicines. Your provider can tell you what additional information is useful.

Is this page medical advice?

The information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

References

  1. U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” FDA source. Used here for regulatory context, not individualized instructions.

About this Kind MD resource

Kind MD is a telehealth platform that connects eligible patients with licensed healthcare providers who may prescribe compounded semaglutide or tirzepatide when clinically appropriate.

A licensed healthcare provider makes an independent prescribing decision when clinically appropriate. Kind MD does not accept or bill insurance; plans are self-pay.

The information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Questions? Reach us at care@kindmd.co.

Have questions about treatment?

Take the free quiz to get started. An independent licensed provider will review your information and determine whether treatment may be appropriate for you.

Take the Free Quiz →